MAP3K1 and disorder of sexual differentiation: Therefore, it was recommended by Granados and his colleagues that testing for MAP3K1 variants should be considered in patients with 46, XY complete or partial gonadal dysgenesis, particularly in families with multiple affected individuals with 46, XY DSD (Granados et al., 2017).